Subscribe to RSS
DOI: 10.1055/s-0039-1698429
Current Concepts in the Epidemiology, Diagnosis, and Management of Histoplasmosis Syndromes
Publication History
Publication Date:
30 January 2020 (online)
Abstract
Histoplasmosis is a global disease endemic to regions of all six inhabited continents. The areas of highest endemicity lie within the Mississippi and Ohio River Valleys of North America and parts of Central and South America. As a result of climate change and anthropogenic land utilization, the conditions suitable for Histoplasma capsulatum are changing, leading to a corresponding change in epidemiology. The clinical manifestations of histoplasmosis are protean, variably resembling other common conditions such as community-acquired pneumonia, tuberculosis, sarcoidosis, Crohn's disease, or malignancy. Making a successful diagnosis is contingent on a thorough understanding of epidemiology, common clinical presentations, and best testing practices for histoplasmosis. While most subclinical or self-limited diseases do not require treatment in immunocompetent patients, all immunocompromised patients and those with progressive disseminated disease or chronic pulmonary disease should be treated. Liposomal amphotericin B is the preferred agent for severe or disseminated disease, while itraconazole is adequate for milder cases and “step-down” therapy following response to amphotericin B. In this review, we discuss the current evidence-based approaches to the epidemiology, diagnosis, and management of histoplasmosis.
-
References
- 1 Edwards LB, Acquaviva FA, Livesay VT, Cross FW, Palmer CE. An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am Rev Respir Dis 1969; 99 (4, Suppl): 1-132
- 2 Manos NE, Ferebee SH, Kerschbaum WF. Geographic variation in the prevalence of histoplasmin sensitivity. Dis Chest 1956; 29 (06) 649-668
- 3 Baddley JW, Winthrop KL, Patkar NM. , et al. Geographic distribution of endemic fungal infections among older persons, United States. Emerg Infect Dis 2011; 17 (09) 1664-1669
- 4 Benedict K, Mody RK. Epidemiology of histoplasmosis outbreaks, United States, 1938–2013. Emerg Infect Dis 2016; 22 (03) 370-378
- 5 Nett RJ, Skillman D, Riek L. , et al. Histoplasmosis in Idaho and Montana, USA, 2012–2013. Emerg Infect Dis 2015; 21 (06) 1071-1072
- 6 Azar MM, Zhang X, Assi R, Hage C, Wheat LJ, Malinis MF. Clinical and epidemiological characterization of histoplasmosis cases in a nonendemic area, Connecticut, United States. Med Mycol 2018; 56 (07) 896-899
- 7 Gandhi V, Ulyanovskiy P, Epelbaum O. Update on the spectrum of histoplasmosis among hispanic patients presenting to a New York City municipal hospital: a contemporary case series. Respir Med Case Rep 2015; 16: 60-64
- 8 Anderson AM, Mehta AK, Wang YF, Jing Qian, Easley K, Nguyen ML. HIV-associated histoplasmosis in a nonendemic area of the United States during the HAART era: role of migration from endemic areas and lack of antiretroviral therapy. J Int Assoc Physicians AIDS Care (Chic) 2010; 9 (05) 296-300
- 9 Maiga AW, Deppen S, Scaffidi BK. , et al. Mapping Histoplasma capsulatum exposure, United States. Emerg Infect Dis 2018; 24 (10) 1835-1839
- 10 Benedict K, Derado G, Mody RK. Histoplasmosis-associated hospitalizations in the United States, 2001–2012. Open Forum Infect Dis 2016; 3 (01) ofv219
- 11 Colombo AL, Tobón A, Restrepo A, Queiroz-Telles F, Nucci M. Epidemiology of endemic systemic fungal infections in Latin America. Med Mycol 2011; 49 (08) 785-798
- 12 Nucci M, Queiroz-Telles F, Tobón AM, Restrepo A, Colombo AL. Epidemiology of opportunistic fungal infections in Latin America. Clin Infect Dis 2010; 51 (05) 561-570
- 13 Damasceno LS, Ramos Jr AN, Alencar CH. , et al. Disseminated histoplasmosis in HIV-infected patients: determinants of relapse and mortality in a north-eastern area of Brazil. Mycoses 2014; 57 (07) 406-413
- 14 Falci DR, Monteiro AA, Braz Caurio CF. , et al. Histoplasmosis, an underdiagnosed disease affecting people living with HIV/AIDS in Brazil: results of a multicenter prospective cohort study using both classical mycology tests and Histoplasma urine antigen detection. Open Forum Infect Dis 2019; 6 (04) ofz073
- 15 Nacher M, Adenis A, Mc Donald S. , et al. Disseminated histoplasmosis in HIV-infected patients in South America: a neglected killer continues on its rampage. PLoS Negl Trop Dis 2013; 7 (11) e2319
- 16 Pietrobon D, Negro-Marquínez L, Kilstein J, Galíndez J, Greca A, Battagliotti C. Disseminated histoplasmosis and AIDS in an Argentine hospital: clinical manifestations, diagnosis and treatment [in Spanish]. Enferm Infecc Microbiol Clin 2004; 22 (03) 156-159
- 17 Tobón AM, Agudelo CA, Rosero DS. , et al. Disseminated histoplasmosis: a comparative study between patients with acquired immunodeficiency syndrome and non-human immunodeficiency virus-infected individuals. Am J Trop Med Hyg 2005; 73 (03) 576-582
- 18 Mata-Essayag S, Colella MT, Roselló A. , et al. Histoplasmosis: a study of 158 cases in Venezuela, 2000–2005. Medicine (Baltimore) 2008; 87 (04) 193-202
- 19 Segura L, Rojas M, Pelaez N. , et al. Disseminated histoplasmosis and human immunodeficiency virus type 1 infection: risk factors in Guatemala. Clin Infect Dis 1997; 25 (02) 343-344
- 20 Gutierrez ME, Canton A, Sosa N, Puga E, Talavera L. Disseminated histoplasmosis in patients with AIDS in Panama: a review of 104 cases. Clin Infect Dis 2005; 40 (08) 1199-1202
- 21 Arango M, Castañeda E, Agudelo CI. , et al; Colombian Histoplasmosis Study Group. Histoplasmosis: results of the Colombian national survey, 1992–2008. Biomedica 2011; 31 (03) 344-356
- 22 Peigne V, Dromer F, Elie C, Lidove O, Lortholary O. ; French Mycosis Study Group. Imported acquired immunodeficiency syndrome-related histoplasmosis in metropolitan France: a comparison of pre-highly active anti-retroviral therapy and highly active anti-retroviral therapy eras. Am J Trop Med Hyg 2011; 85 (05) 934-941
- 23 Antinori S, Magni C, Nebuloni M. , et al. Histoplasmosis among human immunodeficiency virus-infected people in Europe: report of 4 cases and review of the literature. Medicine (Baltimore) 2006; 85 (01) 22-36
- 24 Farina C, Rizzi M, Ricci L, Gabbi E, Caligaris S, Goglio A. Imported and autochthonous histoplasmosis in Italy: new cases and old problems. Rev Iberoam Micol 2005; 22 (03) 169-171
- 25 Hay RJ, White HS, Fields PE, Quamina DB, Dan M, Jones TR. Histoplasmosis in the eastern Caribbean: a preliminary survey of the incidence of the infection. J Trop Med Hyg 1981; 84 (01) 9-12
- 26 Wen FQ, Sun YD, Watanabe K, Yoshida M, Wu JN, Baum GL. Prevalence of histoplasmin sensitivity in healthy adults and tuberculosis patients in southwest China. J Med Vet Mycol 1996; 34 (03) 171-174
- 27 Pan B, Chen M, Pan W, Liao W. Histoplasmosis: a new endemic fungal infection in China? Review and analysis of cases. Mycoses 2013; 56 (03) 212-221
- 28 Norkaew T, Ohno H, Sriburee P. , et al. Detection of environmental sources of Histoplasma capsulatum in Chiang Mai, Thailand, by nested PCR. Mycopathologia 2013; 176 (5–6): 395-402
- 29 Rangwala F, Putcharoen O, Bowonwatanuwong C. , et al. Histoplasmosis and penicilliosis among HIV-infected Thai patients: a retrospective review. Southeast Asian J Trop Med Public Health 2012; 43 (02) 436-441
- 30 Bulmer AC, Bulmer GS. Incidence of histoplasmin hypersensitivity in the Philippines. Mycopathologia 2001; 149 (02) 69-71
- 31 Azar MM, Malinis MF. Disseminated histoplasmosis with skin lesions and osteomyelitis in a patient from the Philippines. Am J Trop Med Hyg 2016; 95 (01) 70-74
- 32 Randhawa HS, Gugnani HC. Occurrence of histoplasmosis in the Indian sub-continent: an overview and update. J Med Res Prac 2018; 7: 71-83
- 33 Pakasa N, Biber A, Nsiangana S. , et al. African histoplasmosis in HIV-negative patients, Kimpese, Democratic Republic of the Congo. Emerg Infect Dis 2018; 24 (11) 2068-2070
- 34 Lofgren SM, Kirsch EJ, Maro VP. , et al. Histoplasmosis among hospitalized febrile patients in northern Tanzania. Trans R Soc Trop Med Hyg 2012; 106 (08) 504-507
- 35 Gumbo T, Just-Nübling G, Robertson V, Latif AS, Borok MZ, Hohle R. Clinicopathological features of cutaneous histoplasmosis in human immunodeficiency virus-infected patients in Zimbabwe. Trans R Soc Trop Med Hyg 2001; 95 (06) 635-636
- 36 Ramdial KP, Mosam A, Dlova NC, Satar BN, Aboobaker J, Singh SM. ; P KR. Disseminated cutaneous histoplasmosis in patients infected with human immunodeficiency virus. J Cutan Pathol 2002; 29 (04) 215-225
- 37 Gugnani HC, Muotoe-Okafor F. African histoplasmosis: a review. Rev Iberoam Micol 1997; 14 (04) 155-159
- 38 Staffolani S, Buonfrate D, Angheben A. , et al. Acute histoplasmosis in immunocompetent travelers: a systematic review of literature. BMC Infect Dis 2018; 18 (01) 673
- 39 Benedict K, Beer KD, Jackson BR. Histoplasmosis-related healthcare use, diagnosis, and treatment in a commercially insured population, United States. Clin Infect Dis 2019 (e-pub ahead of print). Doi: 10.1093/cid/ciz324
- 40 Sethi J, Gupta KL, Mohanty T, Gupta S, Ahluwalia J, Kohli HS. Fever of unknown origin in a renal transplant recipient: lactate dehydrogenase as an important clue to diagnosis. Exp Clin Transplant 2019 (e-pub ahead of print). Doi: 10.6002/ect.2018.0380
- 41 Spec A, Barrios CR, Ahmad U, Proia LA. AST to ALT ratio is elevated in disseminated histoplasmosis as compared to localized pulmonary disease and other endemic mycoses. Med Mycol 2017; 55 (05) 541-545
- 42 Connolly PA, Durkin MM, Lemonte AM, Hackett EJ, Wheat LJ. Detection of histoplasma antigen by a quantitative enzyme immunoassay. Clin Vaccine Immunol 2007; 14 (12) 1587-1591
- 43 Azar MM, Hage CA. Laboratory diagnostics for histoplasmosis. J Clin Microbiol 2017; 55 (06) 1612-1620
- 44 Myint T, Anderson AM, Sanchez A. , et al. Histoplasmosis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS): multicenter study of outcomes and factors associated with relapse. Medicine (Baltimore) 2014; 93 (01) 11-18
- 45 Hage CA, Bowyer S, Tarvin SE, Helper D, Kleiman MB, Wheat LJ. Recognition, diagnosis, and treatment of histoplasmosis complicating tumor necrosis factor blocker therapy. Clin Infect Dis 2010; 50 (01) 85-92
- 46 Assi M, Martin S, Wheat LJ. , et al. Histoplasmosis after solid organ transplant. Clin Infect Dis 2013; 57 (11) 1542-1549
- 47 Assi MA, Sandid MS, Baddour LM, Roberts GD, Walker RC. Systemic histoplasmosis: a 15-year retrospective institutional review of 111 patients. Medicine (Baltimore) 2007; 86 (03) 162-169
- 48 Hage CA, Ribes JA, Wengenack NL. , et al. A multicenter evaluation of tests for diagnosis of histoplasmosis. Clin Infect Dis 2011; 53 (05) 448-454
- 49 Swartzentruber S, Rhodes L, Kurkjian K. , et al. Diagnosis of acute pulmonary histoplasmosis by antigen detection. Clin Infect Dis 2009; 49 (12) 1878-1882
- 50 Wheat LJ, Connolly-Stringfield P, Williams B. , et al. Diagnosis of histoplasmosis in patients with the acquired immunodeficiency syndrome by detection of Histoplasma capsulatum polysaccharide antigen in bronchoalveolar lavage fluid. Am Rev Respir Dis 1992; 145 (06) 1421-1424
- 51 Hage CA, Davis TE, Fuller D. , et al. Diagnosis of histoplasmosis by antigen detection in BAL fluid. Chest 2010; 137 (03) 623-628
- 52 Wheat J, Myint T, Guo Y. , et al. Central nervous system histoplasmosis: multicenter retrospective study on clinical features, diagnostic approach and outcome of treatment. Medicine (Baltimore) 2018; 97 (13) e0245
- 53 Hage CA, Kirsch EJ, Stump TE. , et al. Histoplasma antigen clearance during treatment of histoplasmosis in patients with AIDS determined by a quantitative antigen enzyme immunoassay. Clin Vaccine Immunol 2011; 18 (04) 661-666
- 54 Wheat LJ, Connolly P, Durkin M. , et al. False-positive Histoplasma antigenemia caused by antithymocyte globulin antibodies. Transpl Infect Dis 2004; 6 (01) 23-27
- 55 Kaur A, Eberlein M, Klesney-Tait J, Durkin MM, Wheat LJ, Gajurel K. Rabbit antithymocyte globulin causes Blastomyces and Histoplasma antigenemia. Open Forum Infect Dis 2019; 6 (05) ofz165
- 56 Theel ES, Ramanan P. Clinical significance of low-positive histoplasma urine antigen results. J Clin Microbiol 2014; 52 (09) 3444-3446
- 57 Wheat J, French ML, Kohler RB. , et al. The diagnostic laboratory tests for histoplasmosis: analysis of experience in a large urban outbreak. Ann Intern Med 1982; 97 (05) 680-685
- 58 CSTE. Standardized surveillance case definition for histoplasmosis. 2016 . Available at: https://cdn.ymaws.com/www.cste.org/resource/resmgr/2016PS/16_ID_02.pdf . Accessed September 16, 2019
- 59 Richer SM, Smedema ML, Durkin MM. , et al. Improved diagnosis of acute pulmonary histoplasmosis by combining antigen and antibody detection. Clin Infect Dis 2016; 62 (07) 896-902
- 60 Simon S, Veron V, Boukhari R, Blanchet D, Aznar C. Detection of Histoplasma capsulatum DNA in human samples by real-time polymerase chain reaction. Diagn Microbiol Infect Dis 2010; 66 (03) 268-273
- 61 Stempak LM, Vogel SA, Richter SS, Wyllie R, Procop GW. Routine broad-range fungal polymerase chain reaction with DNA sequencing in patients with suspected mycoses does not add value and is not cost-effective. Arch Pathol Lab Med 2019; 143 (05) 634-638
- 62 Accuprobe. [package insert]. GenProbe Inc., San Diego, CA; 2011 . Available at: http://www.hologic.ca/sites/default/files/package%20inserts/102962RevK.pdf . Accessed Feb 20 2017
- 63 Wilson MR, O'Donovan BD, Gelfand JM. , et al. Chronic meningitis investigated via metagenomic next-generation sequencing. JAMA Neurol 2018; 75 (08) 947-955
- 64 Rubio-Carrasquilla M, Santa CD, Rendón JP, Botero-Garcés J, Moreno E, Cano LE. An interferon gamma release assay specific for Histoplasma capsulatum to detect asymptomatic infected individuals: a proof of concept study. Med Mycol 2018 (e-pub ahead of print). Doi: 10.1093/mmy/myy131
- 65 Valero C, Buitrago MJ, Gago S, Quiles-Melero I, García-Rodríguez J. A matrix-assisted laser desorption/ionization time of flight mass spectrometry reference database for the identification of Histoplasma capsulatum. Med Mycol 2018; 56 (03) 307-314
- 66 Reynolds III RJ, Penn RL, Grafton WD, George RB. Tissue morphology of Histoplasma capsulatum in acute histoplasmosis. Am Rev Respir Dis 1984; 130 (02) 317-320
- 67 Sollod N. Acute fulminating disseminated histoplasmosis. Report of an unusual outbreak. J S C Med Assoc 1971; 67 (05) 231-234
- 68 Wheat LJ, Slama TG, Norton JA. , et al. Risk factors for disseminated or fatal histoplasmosis. Analysis of a large urban outbreak. Ann Intern Med 1982; 96 (02) 159-163
- 69 Wynne JW, Olsen GN. Acute histoplasmosis presenting as the adult respiratory distress syndrome. Chest 1974; 66 (02) 158-161
- 70 Johnson PC, Wheat LJ, Cloud GA. , et al; U.S. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Ann Intern Med 2002; 137 (02) 105-109
- 71 Egressy KvL, Mohammed M, Ferguson JS. The use of endobronchial ultrasound in the diagnosis of subacute pulmonary histoplasmosis. Diagn Ther Endosc 2015; 2015: 6
- 72 Wheat LJ, Wass J, Norton J, Kohler RB, French ML. Cavitary histoplasmosis occurring during two large urban outbreaks. Analysis of clinical, epidemiologic, roentgenographic, and laboratory features. Medicine (Baltimore) 1984; 63 (04) 201-209
- 73 Goodwin Jr RA, Owens FT, Snell JD. , et al. Chronic pulmonary histoplasmosis. Medicine (Baltimore) 1976; 55 (06) 413-452
- 74 Furcolow ML. Comparison of treated and untreated severe histoplasmosis: a communicable disease center cooperative mycoses study. JAMA 1963; 183: 823-829
- 75 Baum GL, Larkin Jr JC, Sutliff WD. Follow-up of patients with chronic pulmonary histoplasmosis treated with amphotericin B. Chest 1970; 58 (06) 562-565
- 76 Mashburn JD, Dawson DF, Young JM. Pulmonary calcifications and histoplasmosis. Am Rev Respir Dis 1961; 84: 208-216
- 77 Straub M, Schwarz J. The healed primary complex in histoplasmosis. Am J Clin Pathol 1955; 25 (07) 727-741
- 78 Mukhopadhyay S, Wilcox BE, Myers JL. , et al. Pulmonary necrotizing granulomas of unknown cause: clinical and pathologic analysis of 131 patients with completely resected nodules. Chest 2013; 144 (03) 813-824
- 79 Deppen S, Putnam Jr JB, Andrade G. , et al. Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous disease. Ann Thorac Surg 2011; 92 (02) 428-432 , discussion 433
- 80 Kadaria D, Archie DS, SultanAli I, Weiman DS, Freire AX, Zaman MK. Dual time point positron emission tomography/computed tomography scan in evaluation of intrathoracic lesions in an area endemic for histoplasmosis and with high prevalence of sarcoidosis. Am J Med Sci 2013; 346 (05) 358-362
- 81 Ost D, Fein AM, Feinsilver SH. Clinical practice. The solitary pulmonary nodule. N Engl J Med 2003; 348 (25) 2535-2542
- 82 Goodwin RA, Alcorn GL. Histoplasmosis with symptomatic lymphadenopathy. Chest 1980; 77 (02) 213-215
- 83 Goodwin RA, Loyd JE, Des Prez RM. Histoplasmosis in normal hosts. Medicine (Baltimore) 1981; 60 (04) 231-266
- 84 Parish JM, Rosenow III EC. Mediastinal granuloma and mediastinal fibrosis. Semin Respir Crit Care Med 2002; 23 (02) 135-143
- 85 Goodwin RA, Nickell JA, Des Prez RM. Mediastinal fibrosis complicating healed primary histoplasmosis and tuberculosis. Medicine (Baltimore) 1972; 51 (03) 227-246
- 86 Johnson JA, Loyd JE, Wheat LJ, Netterville JL. A case series and review of histoplasmosis infection in the neck. Arch Otolaryngol Head Neck Surg 2010; 136 (09) 916-919
- 87 Savides TJ, Gress FG, Wheat LJ, Ikenberry S, Hawes RH. Dysphagia due to mediastinal granulomas: diagnosis with endoscopic ultrasonography. Gastroenterology 1995; 109 (02) 366-373
- 88 Rochester CL, Kradin RL. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 39-2000. A 47-year-old woman with multilobar pulmonary consolidation. N Engl J Med 2000; 343 (25) 1876-1884
- 89 Gula LJ, Malthaner RA, Quantz MA. Pyopneumopericardium caused by mediastinal granuloma. Ann Thorac Surg 2002; 74 (01) 241-243
- 90 Lentz RJ, Lambright ES, Maldonado F, Loyd J, Grogan EL, Rickman OB. Mediastinal granuloma superinfection following ultrasound-guided transbronchial needle aspiration: a case series. Am J Respir Crit Care Med 2016; 193: A3385
- 91 Dines DE, Payne WS, Bernatz PE, Pairolero PC. Mediastinal granuloma and fibrosing mediastinitis. Chest 1979; 75 (03) 320-324
- 92 Loyd JE, Tillman BF, Atkinson JB, Des Prez RM. Mediastinal fibrosis complicating histoplasmosis. Medicine (Baltimore) 1988; 67 (05) 295-310
- 93 Peikert T, Colby TV, Midthun DE. , et al. Fibrosing mediastinitis: clinical presentation, therapeutic outcomes, and adaptive immune response. Medicine (Baltimore) 2011; 90 (06) 412-423
- 94 Westerly BD, Johnson GB, Maldonado F, Utz JP, Specks U, Peikert T. Targeting B lymphocytes in progressive fibrosing mediastinitis. Am J Respir Crit Care Med 2014; 190 (09) 1069-1071
- 95 Albers EL, Pugh ME, Hill KD, Wang L, Loyd JE, Doyle TP. Percutaneous vascular stent implantation as treatment for central vascular obstruction due to fibrosing mediastinitis. Circulation 2011; 123 (13) 1391-1399
- 96 Ponamgi SP, DeSimone CV, Lenz CJ. , et al. Catheter-based intervention for pulmonary vein stenosis due to fibrosing mediastinitis: The Mayo Clinic experience. Int J Cardiol Heart Vasc 2015; 8: 103-107
- 97 Recto MR, Bousamra M, Yeh Jr T. Late superior vena cava perforation and aortic laceration after stenting to treat superior vena cava syndrome secondary to fibrosing mediastinitis. J Invasive Cardiol 2002; 14 (10) 624-629
- 98 Kern R, Peikert T, Edell E. , et al. Bronchoscopic management of airway compression due to fibrosing mediastinitis. Ann Am Thorac Soc 2017; 14 (08) 1353-1355
- 99 Kortsik C, Elmer A, Tamm I. Pleural effusion due to Histoplasma capsulatum and idiopathic CD4 lymphocytopenia. Respiration 2003; 70 (01) 118-122
- 100 Antachopoulos C, Walsh TJ, Roilides E. Fungal infections in primary immunodeficiencies. Eur J Pediatr 2007; 166 (11) 1099-1117
- 101 Alberti-Flor JJ, Granda A. Ileocecal histoplasmosis mimicking Crohn's disease in a patient with Job's syndrome. Digestion 1986; 33 (03) 176-180
- 102 Robinson WS, Arnold SR, Michael CF. , et al. Case report of a young child with disseminated histoplasmosis and review of hyper immunoglobulin e syndrome (HIES). Clin Mol Allergy 2011; 9: 14
- 103 Zerbe CS, Holland SM. Disseminated histoplasmosis in persons with interferon-gamma receptor 1 deficiency. Clin Infect Dis 2005; 41 (04) e38-e41
- 104 Subbalaxmi MV, Umabala P, Paul R, Chandra N, Raju YS, Rudramurthy SM. A rare presentation of progressive disseminated histoplasmosis in an immunocompetent patient from a non-endemic region. Med Mycol Case Rep 2013; 2: 103-107
- 105 Grim SA, Proia L, Miller R. , et al. A multicenter study of histoplasmosis and blastomycosis after solid organ transplantation. Transpl Infect Dis 2012; 14 (01) 17-23
- 106 Miller R, Assi M. ; AST Infectious Diseases Community of Practice. Endemic fungal infections in solid organ transplant recipients-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019; e13553
- 107 Natarajan M, Swierzbinski MJ, Maxwell S. , et al. Pulmonary Histoplasma infection after allogeneic hematopoietic stem cell transplantation: case report and review of the literature. Open Forum Infect Dis 2017; 4 (02) ofx041
- 108 Conces Jr DJ, Stockberger SM, Tarver RD, Wheat LJ. Disseminated histoplasmosis in AIDS: findings on chest radiographs. AJR Am J Roentgenol 1993; 160 (01) 15-19
- 109 Riddell IV J, Kauffman CA, Smith JA. , et al. Histoplasma capsulatum endocarditis: multicenter case series with review of current diagnostic techniques and treatment. Medicine (Baltimore) 2014; 93 (05) 186-193
- 110 Santiago AR, Hernández B, Rodríguez M, Romero H. A comparative study of blood culture conventional method vs. a modified lysis/centrifugation technique for the diagnosis of fungemias [in Spanish]. Rev Iberoam Micol 2004; 21 (04) 198-201
- 111 Ramanan P, Vetter E, Milone AA, Patel R, Wengenack NL. Comparison of BACTEC MYCO/F lytic bottle to the wampole isolator for recovery of fungal and mycobacterial organisms. Open Forum Infect Dis 2016; 3: 1557
- 112 Vetter E, Torgerson C, Feuker A. , et al. Comparison of the BACTEC MYCO/F Lytic bottle to the isolator tube, BACTEC Plus Aerobic F/bottle, and BACTEC Anaerobic Lytic/10 bottle and comparison of the BACTEC Plus Aerobic F/bottle to the Isolator tube for recovery of bacteria, mycobacteria, and fungi from blood. J Clin Microbiol 2001; 39 (12) 4380-4386
- 113 Wheat J, MaWhinney S, Hafner R. , et al; National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Clinical Trials Group and Mycoses Study Group. Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. Am J Med 1997; 103 (03) 223-232
- 114 Freifeld AG, Iwen PC, Lesiak BL, Gilroy RK, Stevens RB, Kalil AC. Histoplasmosis in solid organ transplant recipients at a large Midwestern university transplant center. Transpl Infect Dis 2005; 7 (3–4): 109-115
- 115 Restrepo A, Tobón A, Clark B. , et al. Salvage treatment of histoplasmosis with posaconazole. J Infect 2007; 54 (04) 319-327
- 116 Kraft WK, Chang PS, van Iersel ML, Waskin H, Krishna G, Kersemaekers WM. Posaconazole tablet pharmacokinetics: lack of effect of concomitant medications altering gastric pH and gastric motility in healthy subjects. Antimicrob Agents Chemother 2014; 58 (07) 4020-4025
- 117 Maertens J, Cornely OA, Ullmann AJ. , et al. Phase 1B study of the pharmacokinetics and safety of posaconazole intravenous solution in patients at risk for invasive fungal disease. Antimicrob Agents Chemother 2014; 58 (07) 3610-3617
- 118 Duplessis CA, Tilley D, Bavaro M, Hale B, Holland SM. Two cases illustrating successful adjunctive interferon-γ immunotherapy in refractory disseminated coccidioidomycosis. J Infect 2011; 63 (03) 223-228
- 119 Vinh DC. Insights into human antifungal immunity from primary immunodeficiencies. Lancet Infect Dis 2011; 11 (10) 780-792
- 120 Ibrahim KY, Carvalho NB, Mimicos EV, Yeh-Li H, Sotto MN, França FO. Cutaneous and bone marrow histoplasmosis after 18 years of renal allograft transplant. Mycopathologia 2014; 178 (3–4): 273-278
- 121 Naeem F, Metzger ML, Arnold SR, Adderson EE. Distinguishing benign mediastinal masses from malignancy in a histoplasmosis-endemic region. J Pediatr 2015; 167 (02) 409-415
- 122 Cuellar-Rodriguez J, Avery RK, Lard M. , et al. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area. Clin Infect Dis 2009; 49 (05) 710-716
- 123 Olson TC, Bongartz T, Crowson CS, Roberts GD, Orenstein R, Matteson EL. Histoplasmosis infection in patients with rheumatoid arthritis, 1998–2009. BMC Infect Dis 2011; 11: 145
- 124 Dotson JL, Crandall W, Mousa H. , et al. Presentation and outcome of histoplasmosis in pediatric inflammatory bowel disease patients treated with antitumor necrosis factor alpha therapy: a case series. Inflamm Bowel Dis 2011; 17 (01) 56-61
- 125 Vergidis P, Avery RK, Wheat LJ. , et al. Histoplasmosis complicating tumor necrosis factor-α blocker therapy: a retrospective analysis of 98 cases. Clin Infect Dis 2015; 61 (03) 409-417